CE Mark Approved for Balt's Magic Glue Cyanoacrylate Liquid Embolic Agent

 

October 24, 2018—Balt International announced it has received CE Mark approval for Magic Glue, its next-generation cyanoacrylate liquid embolic agent. Magic Glue is indicated for the embolization of arteriovenous malformations. New features of this cyanoacrylate glue include delayed polymerization of the monomers for better control and less adhesion to the microcatheter, allowing for longer injection. Magic Glue is applicable in the fields of neuroradiology and interventional radiology.

According to the company, Magic Glue is a class III implantable medical device that is described as an arterial and venous embolization implant because of its hemostatic action. It is applied in solution with a contrast liquid.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.